Schroeder KW - Search Results

1

Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study.

Schroeder KW, Tremaine WJ, Ilstrup DM. Schroeder KW, et al. N Engl J Med. 1987 Dec 24;317(26):1625-9. doi: 10.1056/NEJM198712243172603. N Engl J Med. 1987. PMID: 3317057 Clinical Trial.

2

Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures.

Samuel S, Bruining DH, Loftus EV Jr, Thia KT, Schroeder KW, Tremaine WJ, Faubion WA, Kane SV, Pardi DS, de Groen PC, Harmsen WS, Zinsmeister AR, Sandborn WJ. Samuel S, et al. Among authors: schroeder kw. Clin Gastroenterol Hepatol. 2013 Jan;11(1):49-54.e1. doi: 10.1016/j.cgh.2012.08.003. Epub 2012 Aug 16. Clin Gastroenterol Hepatol. 2013. PMID: 22902762

3

Measurement of disease activity in ulcerative colitis: interobserver agreement and predictors of severity.

Thia KT, Loftus EV Jr, Pardi DS, Kane SV, Faubion WA, Tremaine WJ, Schroeder KW, Harmsen SW, Zinsmeister AR, Sandborn WJ. Thia KT, et al. Among authors: schroeder kw. Inflamm Bowel Dis. 2011 Jun;17(6):1257-64. doi: 10.1002/ibd.21480. Epub 2010 Sep 27. Inflamm Bowel Dis. 2011. PMID: 20878712

4

Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications.

Schroeder KW. Schroeder KW. Scand J Gastroenterol Suppl. 2002;(236):42-7. doi: 10.1080/003655202320621445. Scand J Gastroenterol Suppl. 2002. PMID: 12408503 Review.

5

Cyclosporine enemas for treatment-resistant, mildly to moderately active, left-sided ulcerative colitis.

Sandborn WJ, Tremaine WJ, Schroeder KW, Steiner BL, Batts KP, Lawson GM. Sandborn WJ, et al. Among authors: schroeder kw. Am J Gastroenterol. 1993 May;88(5):640-5. Am J Gastroenterol. 1993. PMID: 8480724 Clinical Trial.

6

A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis.

Sandborn WJ, Tremaine WJ, Schroeder KW, Batts KP, Lawson GM, Steiner BL, Harrison JM, Zinsmeister AR. Sandborn WJ, et al. Among authors: schroeder kw. Gastroenterology. 1994 Jun;106(6):1429-35. doi: 10.1016/0016-5085(94)90394-8. Gastroenterology. 1994. PMID: 8194687 Clinical Trial.

7

A randomized, double-blind, placebo-controlled trial of the oral mesalamine (5-ASA) preparation, Asacol, in the treatment of symptomatic Crohn's colitis and ileocolitis.

Tremaine WJ, Schroeder KW, Harrison JM, Zinsmeister AR. Tremaine WJ, et al. Among authors: schroeder kw. J Clin Gastroenterol. 1994 Dec;19(4):278-82. doi: 10.1097/00004836-199412000-00003. J Clin Gastroenterol. 1994. PMID: 7876505 Clinical Trial.

8

Lung disease associated with orally administered mesalamine for ulcerative colitis.

Reinoso MA, Schroeder KW, Pisani RJ. Reinoso MA, et al. Among authors: schroeder kw. Chest. 1992 May;101(5):1469-71. doi: 10.1378/chest.101.5.1469. Chest. 1992. PMID: 1582327

9

Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance.

Taylor BA, Pemberton JH, Carpenter HA, Levin KE, Schroeder KW, Welling DR, Spencer MP, Zinsmeister AR. Taylor BA, et al. Among authors: schroeder kw. Dis Colon Rectum. 1992 Oct;35(10):950-6. doi: 10.1007/BF02253497. Dis Colon Rectum. 1992. PMID: 1395982

10

Distribution of mesalamine enemas in patients with active distal ulcerative colitis.

Chapman NJ, Brown ML, Phillips SF, Tremaine WJ, Schroeder KW, Dewanjee MK, Zinsmeister AR. Chapman NJ, et al. Among authors: schroeder kw. Mayo Clin Proc. 1992 Mar;67(3):245-8. doi: 10.1016/s0025-6196(12)60100-1. Mayo Clin Proc. 1992. PMID: 1545592

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results